Cue Biopharma, Inc. (CUE) › Capital ExpendituresCue Biopharma, Inc. (CUE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $1.03M2018: $1.85M2019: $46.4K2020: $595.3K2021: $913.0K2022: $171.0K2023: $02024: $66.0K2025: $177.0K$177.0K2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$177.0K+168.2%2024$66.0K—2023$0-100.0%2022$171.0K-81.3%2021$913.0K+53.4%2020$595.3K+1184.2%2019$46.4K-97.5%2018$1.85M+80.0%2017$1.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share